 single-blind comparison intravenous ondansetron selective serotonin antagonist intravenous metoclopramide prevention nausea vomiting high-dose cisplatin chemotherapy Ondansetron GR selective antagonist serotonin subtype receptors effective prevention emesis cisplatin chemotherapeutic agents randomized single-blind multicenter parallel group study efficacy safety intravenous IV ondansetron IV metoclopramide prevention nausea vomiting high-dose equal cisplatin chemotherapy patients first dose cisplatin combination antineoplastic agents ondansetron mg/kg IV hours doses mg/kg IV hours doses hours additional doses study concurrent administration antiemetics dexamethasone Patients ondansetron rate complete protection emesis complete major response rate rate failure median number emetic episodes median time first emetic episode ondansetron hours Adverse events patients ondansetron metoclopramide Akathisia dystonic reactions metoclopramide headache acetaminophen frequent ondansetron Ondansetron effective adverse events metoclopramide prevention emesis high-dose cisplatin chemotherapy